Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare (CROSBI ID 298683)
Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija
Podaci o odgovornosti
Bilić Ćurčić, Ines ; Cigrovski Berković, Maja ; Kizivat, Tomislav ; Canecki Varžić, Silvija ; Smolić, Robert ; Smolić, Martina
engleski
Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare
The new coronavirus disease 2019 (COVID-19) pandemic posed a great burden on health care systems worldwide and is an enormous and real obstacle in providing needed health care to patients with chronic diseases such as diabetes. Parallel to COVID-19, there have been great advances in technology used for management of type 1 diabetes, primarily insulin pumps, sensors, integrated and closed loop systems, ambulatory glucose profile software, and smart phone apps providing necessary essentials for telemedicine implementation right at the beginning of the COVID-19 pandemic. The results of these remote interventions are reassuring in terms of glycemic management and hemoglobin A1c reductions. However, data on long-term outcomes and cost reductions are missing as well as proper technical infrastructure and government health policy support.
Diabetes management ; Telemedicine ; COVID-19 ; Diabetes type 1
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Kliničke medicinske znanosti, Temeljne medicinske znanosti